These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28965809)

  • 1. Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.
    Fujimaki K; Toki S; Yamashita H; Oyamada T; Yamawaki S
    Psychiatry Res; 2018 Apr; 262():600-608. PubMed ID: 28965809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of quality of life in inpatients with schizophrenia.
    Fujimaki K; Morinobu S; Yamashita H; Takahashi T; Yamawaki S
    Psychiatry Res; 2012 May; 197(3):199-205. PubMed ID: 22370148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse association between negative symptoms and body mass index in chronic schizophrenia.
    Mezquida G; Savulich G; Garcia-Rizo C; Garcia-Portilla MP; Toll A; Garcia-Alvarez L; Bobes J; Mané A; Bernardo M; Fernandez-Egea E
    Schizophr Res; 2018 Feb; 192():69-74. PubMed ID: 28412089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsessive-compulsive disorder and obsessive-compulsive symptoms in Japanese inpatients with chronic schizophrenia - a possible schizophrenic subtype.
    Owashi T; Ota A; Otsubo T; Susa Y; Kamijima K
    Psychiatry Res; 2010 Oct; 179(3):241-6. PubMed ID: 20483470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning.
    Zhou Y; Rosenheck R; Mohamed S; Zhang J; Chang Q; Ou Y; Sun B; Ning Y; He H
    Schizophr Res; 2015 Feb; 161(2-3):376-81. PubMed ID: 25533592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms in Chinese male inpatients with schizophrenia: Prevalence and clinical correlates.
    Xu YM; Li F; Liu XB; Zhong BL
    Psychiatry Res; 2018 Jun; 264():380-384. PubMed ID: 29677621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between estradiol and negative symptoms in men with schizophrenia.
    Kaneda Y; Ohmori T
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):239-42. PubMed ID: 15939980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which aspects of long-term outcome are predicted by positive and negative symptoms in early-onset psychosis? An exploratory eight-year follow-up study.
    Remberk B; Bażyńska AK; Bronowska Z; Potocki P; Krempa-Kowalewska A; Niwiński P; Rybakowski F
    Psychopathology; 2015; 48(1):47-55. PubMed ID: 25471137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QTc interval in a sample of long-term schizophrenia inpatients.
    Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
    Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.
    Gebhardt S; Härtling F; Hanke M; Theisen FM; von Georgi R; Grant P; Mittendorf M; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):44-53. PubMed ID: 17876506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.
    Fujimaki K; Takahashi T; Morinobu S
    PLoS One; 2012; 7(5):e37087. PubMed ID: 22615901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.